PEPTIDE Registry

Reported experiences and published evidence, kept separate. Explore what people seek, what sources actually study and what remains unknown.

Collection closed. No participant results published.

What would you like to explore?

All groups and topics

Reported-use topics, not evidence grades or diagnoses. The catalog does not cover every possible experience.

TB-500

Editorial context from existing sources; independent scientific review pending. Numerical findings held. A reported-use topic does not establish direct evidence for that aim.

The FDA scientific assessment distinguishes TB-500-related substances from full-length thymosin beta-4. A topical ocular trial of the latter does not test injected vendor TB-500.

The ocular trial’s primary endpoints were not positive, despite some secondary findings. Neither those findings nor laboratory data establish systemic repair-stack effectiveness.

Sources and proposed-mechanism explanation

Claims borrow from thymosin beta-4 biology, including cell migration and repair. Evidence transfer requires the same molecule, not a shared name.

Practice & Evidence: claims and limits

Collection, review and methods

8 documents · 24 educational profiles · 10 guides. Hosting authorization and reviews remain pending. Drafts are not reports; they do not establish effectiveness or safety.

Methods, consent and privacy

Understanding community practices What each evidence label means Stacks, mixtures and claims of synergy How we handle reported doses and cycles Reading a peptide quality report When someone says it worked Source errors, corrections and retractions From experience to a research question The proposed Community Observation Program Reading future observational results